Bank of America’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Buy |
23,758
+19,054
| +405% | +$168K | ﹤0.01% | 5213 |
|
|
2025
Q1 | $50.6K | Sell |
4,704
-3,411
| -42% | -$36.7K | ﹤0.01% | 5733 |
|
|
2024
Q4 | $104K | Sell |
8,115
-323
| -4% | -$4.13K | ﹤0.01% | 5506 |
|
|
2024
Q3 | $233K | Buy |
8,438
+1,295
| +18% | +$35.7K | ﹤0.01% | 5074 |
|
|
2024
Q2 | $207K | Sell |
7,143
-3,831
| -35% | -$111K | ﹤0.01% | 5061 |
|
|
2024
Q1 | $489K | Sell |
10,974
-72,055
| -87% | -$3.21M | ﹤0.01% | 4561 |
|
|
2023
Q4 | $3.22M | Buy |
83,029
+46,624
| +128% | +$1.81M | ﹤0.01% | 3262 |
|
|
2023
Q3 | $1.07M | Buy |
36,405
+11,894
| +49% | +$350K | ﹤0.01% | 3987 |
|
|
2023
Q2 | $1.56M | Sell |
24,511
-12,429
| -34% | -$790K | ﹤0.01% | 3713 |
|
|
2023
Q1 | $1.74M | Buy |
36,940
+4,816
| +15% | +$227K | ﹤0.01% | 3812 |
|
|
2022
Q4 | $2.23M | Buy |
32,124
+19,631
| +157% | +$1.36M | ﹤0.01% | 3579 |
|
|
2022
Q3 | $1.83M | Buy |
12,493
+4,784
| +62% | +$701K | ﹤0.01% | 3729 |
|
|
2022
Q2 | $1.01M | Sell |
7,709
-1,633
| -17% | -$213K | ﹤0.01% | 4246 |
|
|
2022
Q1 | $943K | Buy |
9,342
+4,984
| +114% | +$503K | ﹤0.01% | 4659 |
|
|
2021
Q4 | $675K | Buy |
4,358
+4,256
| +4,173% | +$659K | ﹤0.01% | 4878 |
|
|
2021
Q3 | $30K | Sell |
102
-3,121
| -97% | -$918K | ﹤0.01% | 6363 |
|
|
2021
Q2 | $1.05M | Buy |
+3,223
| New | +$1.05M | ﹤0.01% | 4211 |
|